Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Morgane C Mouslim

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
The American Journal of Managed Care|February 21, 2024
Facts about hospital-insurer contractingMorgan Henderson, Morgane C Mouslim
The American Journal of Managed Care|August 15, 2024
Cross-validation of insurer and hospital price transparency dataMorgan A Henderson, Morgane C Mouslim
Health Affairs (Project Hope)|July 5, 2022
Hospital And Regional Characteristics Associated With Emergency Department Facility Fee Cash PricingMorgan A Henderson, Morgane C Mouslim
The American Journal of Managed Care|January 9, 2026
Trends in hospital pricing for vulnerable emergency department users, 2021-2023Morgane C Mouslim, Simone Singh, Morgan A Henderson
Breast Cancer Research and Treatment|January 27, 2020
Healthcare system distrust and the breast cancer continuum of careMorgane C Mouslim, Renee M Johnson, Lorraine T Dean
Expert Opinion on Biological Therapy|October 8, 2024
Dynamics of biological markets with multiple biosimilar competitors in the United StatesMorgane C Mouslim, Mariana P Socal, Antonio J Trujillo
Pharmacoeconomics - Open|November 3, 2023
Exploring the Influence of Health Insurance Plans on Biosimilar Adoption RatesJeremy Costin, Morgane C Mouslim, Mariana P Socal, et al.
Expert Opinion on Biological Therapy|May 10, 2022
Dynamics of biosimilar uptake in emerging marketsHemlata Chhabra, Morgane C Mouslim, Smita Kashiramka, et al.
Therapeutic Innovation & Regulatory Science|November 16, 2025
Regulatory Requirements for Interchangeable Biosimilar DesignationPraveen J Samy, Morgane C Mouslim, Charles L Bennett, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|November 29, 2020
Association Between Filgrastim Biosimilar Availability and Changes in Claim Payments and Patient Out-of-Pocket Costs for Biologic Filgrastim ProductsMorgane C Mouslim, Antonio J Trujillo, G Caleb Alexander, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
The American Journal of Managed Care|February 21, 2024
Facts about hospital-insurer contractingMorgan Henderson, Morgane C Mouslim
The American Journal of Managed Care|August 15, 2024
Cross-validation of insurer and hospital price transparency dataMorgan A Henderson, Morgane C Mouslim
Health Affairs (Project Hope)|July 5, 2022
Hospital And Regional Characteristics Associated With Emergency Department Facility Fee Cash PricingMorgan A Henderson, Morgane C Mouslim
The American Journal of Managed Care|January 9, 2026
Trends in hospital pricing for vulnerable emergency department users, 2021-2023Morgane C Mouslim, Simone Singh, Morgan A Henderson
Breast Cancer Research and Treatment|January 27, 2020
Healthcare system distrust and the breast cancer continuum of careMorgane C Mouslim, Renee M Johnson, Lorraine T Dean
Expert Opinion on Biological Therapy|October 8, 2024
Dynamics of biological markets with multiple biosimilar competitors in the United StatesMorgane C Mouslim, Mariana P Socal, Antonio J Trujillo
Pharmacoeconomics - Open|November 3, 2023
Exploring the Influence of Health Insurance Plans on Biosimilar Adoption RatesJeremy Costin, Morgane C Mouslim, Mariana P Socal, et al.
Expert Opinion on Biological Therapy|May 10, 2022
Dynamics of biosimilar uptake in emerging marketsHemlata Chhabra, Morgane C Mouslim, Smita Kashiramka, et al.
Therapeutic Innovation & Regulatory Science|November 16, 2025
Regulatory Requirements for Interchangeable Biosimilar DesignationPraveen J Samy, Morgane C Mouslim, Charles L Bennett, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|November 29, 2020
Association Between Filgrastim Biosimilar Availability and Changes in Claim Payments and Patient Out-of-Pocket Costs for Biologic Filgrastim ProductsMorgane C Mouslim, Antonio J Trujillo, G Caleb Alexander, et al.
Pageof 2